Literature DB >> 2161920

Feline immunodeficiency virus: a neurotropic lentivirus.

S W Dow1, M L Poss, E A Hoover.   

Abstract

We have investigated the neurotropism of feline immunodeficiency virus (FIV) in naturally and experimentally infected cats. Antibodies to FIV were detected in the cerebrospinal fluid (CSF) of 9 of 10 naturally infected cats, and the virus was cultured from the CSF of 5 of 9 of these cats. After experimental intrathecal or intra-bone-marrow inoculation, FIV antibodies were detected in CSF, as were CSF pleocytosis, increased IgG concentration, and elevated CSF IgG index. Brain lesions consisting of perivascular mononuclear cell infiltrates and both glial nodules and diffuse gliosis were observed in the midbrain and thalamus 7 months after inoculation. Virus was recovered by primary culture of brain tissue from several brain regions (cerebral cortex, caudate nucleus, midbrain, cerebellum, rostral and caudal brainstem) but was not recovered from choroid plexus. In vitro, FIV infected primary cultures of feline astrocytes and brain macrophages. Infection of astrocytes resulted in early syncytium formation, production of infectious virions, and eventual cell death. In brain macrophages, FIV infection was noncytopathic. Productive infection of feline neurons or oligodendrocytes was not observed. We conclude that FIV is a neurotropic lentivirus and that FIV infection of feline CNS may serve as a useful model for study of human immune deficiency virus infection of the human CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161920

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  70 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes.

Authors:  K Nakagaki; K Nakagaki; K Takahashi; D Schols; E De Clercq; T Tabira
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

3.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

Review 4.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

6.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 7.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.

Authors:  Chris K Grant; Elizabeth A Fink; Magnus Sundstrom; Bruce E Torbett; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

9.  Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.

Authors:  E B Stephens; E Monck; K Reppas; E J Butfiloski
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

Authors:  Salvador Huitron-Resendiz; Sohela De Rozières; Manuel Sanchez-Alavez; Bernd Bühler; Ying-Chuan Lin; Danica L Lerner; Nicholas W Henriksen; Mboya Burudi; Howard S Fox; Bruce E Torbett; Steven Henriksen; John H Elder
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.